Pharmaceutical-Induced Dyskinesia: A Case Study of Thoracotomy Treated with Amantadine

Mojtaba Mojtahedzadeh; Atabak Najafi; Farahnaz Hosseinzadeh; Fatemeh Saghafi

doi:10.18502/crcp.v9i4.17983

Case Reports in Clinical Practice (Feb 2025)

Pharmaceutical-Induced Dyskinesia: A Case Study of Thoracotomy Treated with Amantadine

Mojtaba Mojtahedzadeh,
Atabak Najafi,
Farahnaz Hosseinzadeh,
Fatemeh Saghafi

Affiliations

Mojtaba Mojtahedzadeh: Department of Clinical Pharmacy, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
Atabak Najafi: Department of Anesthesiology and Critical Care Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Farahnaz Hosseinzadeh: Pharmaceutical Sciences Research Center, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Fatemeh Saghafi: Department of Clinical Pharmacy, School of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

DOI: https://doi.org/10.18502/crcp.v9i4.17983
Journal volume & issue: Vol. 9, no. 4

Abstract

Read online

Dyskinesia, marked by involuntary and irregular movements, can result from various pharmaceutical agents. The case presented features a patient undergoing thoracotomy, experiencing dyskinesia, likely attributed to antipsychotics, antiemetics, and antibiotics, and subsequently treated with amantadine.

Published in Case Reports in Clinical Practice

ISSN: 2538-2683 (Print); 2538-2691 (Online)
Publisher: Tehran University of Medical Sciences
Country of publisher: Iran, Islamic Republic of
LCC subjects: Medicine
Website: https://crcp.tums.ac.ir

About the journal

Abstract

Keywords